Skip to content
Disclosery

Exor N.V.

Follow

13F filer, CIK 1589122, Amsterdam, Netherlands

Exor N.V. reported $4,653,068,702 across 2 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004315

Period
2025-03-31
Reported value
$4.65B
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
0added+8,225,663$209M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-004315, largest first. % of portfolio is the value over $4,653,068,702, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
00Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 164,553,857 shares; 2024Q4: 164,553,857 shares; 2025Q1: 172,779,520 shares 172,779,520$4.39B94.32%+8,225,663
CLVTCLARIVATE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 67,294,884 shares; 2024Q4: 67,294,884 shares; 2025Q1: 67,294,884 shares 67,294,884$264M5.68%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-004315 base2025-05-08acceptance time not in the bulk data set